ST. LOUIS, MO, UNITED STATES, April 15, 2025 /EINPresswire / -- Immunophotonics, Inc., a clinical-stage biotech company focused on im ...

Fintel reports that on April 15, 2025, Cantor Fitzgerald upgraded their outlook for Verve Therapeutics (NasdaqGS:VERV) from ...

It is time to showcase the names and faces of the future who are set to shape and define the technology sector in 2025, and ...

Sara Bullis shows that anyone can be involved in agriculture and Farm Bureau as long as they have passion. Sara currently ...

NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, is pleased to announce the appointment of ...

Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 6.62%, which has investors questioning if this is right time to ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Fintel reports that on April 15, 2025, Jones Trading downgraded their outlook for Rallybio (NasdaqGS:RLYB) from Buy to Hold.

Enanta Pharmaceuticals, Inc.’s ENTA share price has surged by 5.48%, which has investors questioning if this is right time to sell.

NEP 2020 envisions - an education system that is multidisciplinary, flexible and holistic, preparing students not just for jobs but for life. This is particularly significant for pharmacy education, ...

With the business potentially at an important milestone, we thought we'd take a closer look at XOMA Royalty Corporation's (NASDAQ:XOMA) future prospects. XOMA Royalty Corporation operates as a biotech ...